ACXP

Acurx Pharmaceuticals, Inc.

HealthcareBiotechnologyUSUSDPeers →

$1.54

LiveJun 17, 2026

Market cap

$2.44M

52w range

1.33 – 13.70

P / E

—

EPS

—

Volume

78.71K

Revenue · FY

—

Explain this page

Arphra AIPlain-English read on Acurx Pharmaceuticals, Inc.’s valuation

Enterprise value

-$6.77M

Market cap

$2.49M

Net debt

—

Total debt

—

Cash & ST inv.

—

Capital structure

· balance sheet · 2026-06-16

Market capitalisation$2.49M

+ Total debt+—

− Cash & short-term investments−—

= Enterprise value-$6.77M

Valuation

· key metrics · TTM

EV / EBITDA—

EV / Sales0.0×

EV / FCF1.1×

Net debt / EBITDA1.2×

Debt / Equity—

Arphra AIPlain-English read on the EV build & leverage